Literature DB >> 15767483

Perceived barriers to diabetic eye care: qualitative study of patients and physicians.

M Elizabeth Hartnett1, Ira J Key, Natalie M Loyacano, Ronald L Horswell, Karen B Desalvo.   

Abstract

OBJECTIVES: To address inadequate retinopathy screening at a largely indigent clinic and to explore perceived barriers, using qualitative techniques.
METHODS: Responses were analyzed from structured focus groups of patients and key informant interviews of primary diabetic physicians and ophthalmologists at the Medical Center of Louisiana in New Orleans. The number of diabetic patients screened at the center from 2000 to 2002 was obtained by quantitative analysis of an administrative database.
RESULTS: Participants cited finances as the major barrier, while physicians cited inadequate patient education. Patients largely believed that diabetic education was adequate, yet there was a gap between patient education provided and their understanding. All sources agreed that poor access to care, particularly the 1-year wait for an appointment, was a barrier. No respondent mentioned constraints of the system to provide eye care to the number of diabetic patients as a possible barrier, despite the 1-year wait for an eye appointment and a 29% increase in eye examinations within 2 years.
CONCLUSIONS: Perceptions of barriers to diabetic eye care differed among physicians and patients, although both groups agreed that access to care was a barrier. A gap exists between educational material provided to patients and what patients understand. A large unrecognized workload stresses the capacity of the current system.

Entities:  

Mesh:

Year:  2005        PMID: 15767483     DOI: 10.1001/archopht.123.3.387

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  54 in total

Review 1.  Clinical and Psychosocial Factors Influencing Retinal Screening Uptake Among Young Adults with Type 2 Diabetes.

Authors:  A J Lake; G Rees; J Speight
Journal:  Curr Diab Rep       Date:  2018-05-24       Impact factor: 4.810

2.  Factors Associated with Adherence to Screening Guidelines for Diabetic Retinopathy Among Low-Income Metropolitan Patients.

Authors:  Jessica Kuo; James C Liu; Ella Gibson; P Kumar Rao; Todd P Margolis; Bradley Wilson; Mae O Gordon; Emily Fondahn; Rithwick Rajagopal
Journal:  Mo Med       Date:  2020 May-Jun

3.  Telemedicine and Diabetic Retinopathy: Review of Published Screening Programs.

Authors:  Kevin Tozer; Maria A Woodward; Paula A Newman-Casey
Journal:  J Endocrinol Diabetes       Date:  2015-11-11

4.  Teleophthalmic Approach for Detection of Corneal Diseases: Accuracy and Reliability.

Authors:  Maria A Woodward; David C Musch; Christopher T Hood; Jonathan B Greene; Leslie M Niziol; V Swetha E Jeganathan; Paul P Lee
Journal:  Cornea       Date:  2017-10       Impact factor: 2.651

Review 5.  Clinical Components of Telemedicine Programs for Diabetic Retinopathy.

Authors:  Mark B Horton; Paolo S Silva; Jerry D Cavallerano; Lloyd Paul Aiello
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

6.  Diabetic Retinopathy: Focus on Minority Populations.

Authors:  Arpine Barsegian; Boleslav Kotlyar; Justin Lee; Moro O Salifu; Samy I McFarlane
Journal:  Int J Clin Endocrinol Metab       Date:  2017-11-11

7.  Nonmydriatic fundus photography for teleophthalmology diabetic retinopathy screening in rural and urban clinics.

Authors:  Eric K Chin; Bruna V Ventura; Kai-Yin See; Joann Seibles; Susanna S Park
Journal:  Telemed J E Health       Date:  2013-11-12       Impact factor: 3.536

Review 8.  Scaling Up Teleophthalmology for Diabetic Eye Screening: Opportunities for Widespread Implementation in the USA.

Authors:  Yao Liu; Alejandra Torres Diaz; Ramsey Benkert
Journal:  Curr Diab Rep       Date:  2019-08-02       Impact factor: 4.810

9.  Teleretinal imaging to screen for diabetic retinopathy in the Veterans Health Administration.

Authors:  Anthony A Cavallerano; Paul R Conlin
Journal:  J Diabetes Sci Technol       Date:  2008-01

Review 10.  Diabetic Eye Screening: Knowledge and Perspectives from Providers and Patients.

Authors:  Yao Liu; Rebecca Swearingen
Journal:  Curr Diab Rep       Date:  2017-08-31       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.